NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
18/06/2024
Voltar para busca
Dado oficial do USPTO
APOTEX 360
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
APOTEX 360
ST13
US500000088372311Classe
9, 35, 41, 42, 44
Pedido
88372311
Registro
7416703
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
78
Atualização mais recente
18/06/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 35, 41, 42, 44
Data de depósito
04/04/2019
Data de registro
18/06/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/06/2024
Última transação
18/06/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
03
Localização do titular
Toronto, Ontario, CA
Examinador
BERNS, LEE-ANNE
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
APOTEX INC.
Apotex Technologies Inc.
Representantes
Jessica G. Kraver Katten Muchin Rosenman LLP
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer application software for mobile phonesportable media playershandheld tabletscomputerssoftware for internet and/or mobile access to medical contentmedical calculatorshealthcare news and other pharmacy management resources directed to enhance patient care and advance pharmacy practice; Downloadable computer softwaresoftware applications allowing healthcare professionalspharmaciststheir assistants and sales employees to access medical and pharmaceutical related reference data for use in advising on drug usedrug interactions and medical counselling stored in a centralized database in real timeusing a mobile computer device or computers; Downloadable electronic newslettersin the field of patient caremedicationhealthpharmaceuticalmedical and clinical related questions and issues
Classe 35
Business information services provided to the healthcare industryprovision of reportsindustry analysisnews and industry trends in the field of patient caremedicationmedicinehealthcare and pharmacy for business purposes
Classe 41
Providing patient education resources via a website in the nature of providing non-downloadable electronic newsletters in the field of patient caremedicationhealthpharmaceuticalmedical and clinical related questions and issues for patients
Classe 42
Providing online-non-downloadable computer application software for mobile phonesportable media playershandheld tabletscomputerssoftware for internet and/or mobile access to medical contentmedical calculatorshealthcare news and other pharmacy management resources directed to enhance patient care and advance pharmacy practice; Providing on-linenon-downloadable computer softwaresoftware applications allowing healthcare professionalspharmaciststheir assistants and sales employees to access medical and pharmaceutical related reference data for use in advising on drug usedrug interactions and medical counselling stored in a centralized database in real timeusing a mobile computer device or computers
Classe 44
Advisory services in the nature of medical and pharmaceutical consultation in the fields of patient caremedicationhealthpharmaceuticalmedical and clinical related questions and issues; Digital platform in the nature of an online database of patient medical information that provides information relating to patient caremedicationmedicalhealthpharmaceutical and clinical related questions and issues
Publicações
Histórico de despachos e eventos da marca no USPTO.
78 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
18/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/04/2024
PUBO
PUBLISHED FOR OPPOSITION
02/04/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/02/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
27/02/2024
GRML
CORRESPONDENCE E-MAILED
27/02/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/02/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/12/2023
GNRT
NON-FINAL ACTION E-MAILED
27/12/2023
CNRT
NON-FINAL ACTION WRITTEN
27/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/11/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
31/10/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
27/10/2023
GNSL
LETTER OF SUSPENSION E-MAILED
27/10/2023
CNSL
SUSPENSION LETTER WRITTEN
27/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/09/2023
NREV
NOTICE OF REVIVAL - E-MAILED
20/09/2023
PETG
PETITION TO REVIVE-GRANTED
20/09/2023
PROA
TEAS PETITION TO REVIVE RECEIVED
20/09/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
19/07/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/07/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
19/07/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/07/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/07/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/07/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
12/06/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
12/06/2023
CNSI
SUSPENSION INQUIRY WRITTEN
12/06/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/05/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/11/2022
GNSL
LETTER OF SUSPENSION E-MAILED
03/11/2022
CNSL
SUSPENSION LETTER WRITTEN
03/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/10/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/10/2022
ALIE
ASSIGNED TO LIE
12/10/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/10/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/05/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/05/2022
CNSI
SUSPENSION INQUIRY WRITTEN
08/05/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/10/2021
GNSL
LETTER OF SUSPENSION E-MAILED
05/10/2021
CNSL
SUSPENSION LETTER WRITTEN
05/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/09/2021
ALIE
ASSIGNED TO LIE
07/09/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/09/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
30/03/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
30/03/2021
CNSI
SUSPENSION INQUIRY WRITTEN
30/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/03/2021
ALIE
ASSIGNED TO LIE
09/03/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/12/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
06/07/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
06/07/2020
CNSI
SUSPENSION INQUIRY WRITTEN
06/07/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
22/12/2019
GNSL
LETTER OF SUSPENSION E-MAILED
22/12/2019
CNSL
SUSPENSION LETTER WRITTEN
22/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/12/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/07/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/06/2019
GNRT
NON-FINAL ACTION E-MAILED
18/06/2019
CNRT
NON-FINAL ACTION WRITTEN
18/06/2019
DOCK
ASSIGNED TO EXAMINER
14/06/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/04/2019
NWAP
NEW APPLICATION ENTERED
08/04/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace APOTEX 360 ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.